Oncocyte Corp Stock Price on December 14, 2024
| OCX Stock | USD 2.32 0.07 2.93% |
Below is the normalized historical share price chart for OncoCyte Corp extending back to December 30, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of OncoCyte Corp stands at 2.32, as last reported on the 14th of December 2024, with the highest price reaching 2.48 and the lowest price hitting 2.31 during the day.
If you're considering investing in OncoCyte Stock, it is important to understand the factors that can impact its price. OncoCyte Corp maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13% return per unit of risk over the last 3 months. OncoCyte Corp exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check OncoCyte Corp's Variance of 9.91, coefficient of variation of (807.04), and Risk Adjusted Performance of (0.08) to confirm the risk estimate we provide.
At this time, OncoCyte Corp's Common Stock Total Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 8 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 22 M in 2024. . Price Earnings To Growth Ratio is likely to rise to 0.01 in 2024, whereas Price To Sales Ratio is likely to drop 12.09 in 2024. OncoCyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of January 2016 | 200 Day MA 2.9126 | 50 Day MA 2.8358 | Beta 1.002 |
OncoCyte |
Sharpe Ratio = -0.1345
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OCX |
Estimated Market Risk
| 3.18 actual daily | 28 72% of assets are more volatile |
Expected Return
| -0.43 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average OncoCyte Corp is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of OncoCyte Corp by adding OncoCyte Corp to a well-diversified portfolio.
Price Book 4.1434 | Enterprise Value Ebitda (1.25) | Price Sales 56.7505 | Shares Float 5.6 M | Wall Street Target Price 4.125 |
Related Headline
Castle Biosciences Headline on 13th of December 2024
Novo Nordisks diabetes drug, Ozempic, receives positive CHMP opinion in the EU for expanded use in T2D and CKD patients.
OncoCyte Corp Valuation on December 14, 2024
It is possible to determine the worth of OncoCyte Corp on a given historical date. On December 14, 2024 OncoCyte was worth 2.48 at the beginning of the trading date compared to the closed value of 2.32. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of OncoCyte Corp stock. Still, in general, we apply an absolute valuation method to find OncoCyte Corp's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of OncoCyte Corp where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against OncoCyte Corp's related companies.
| Open | High | Low | Close | Volume | |
| 2.40 | 2.47 | 2.34 | 2.39 | 8,258 | |
12/13/2024 | 2.48 | 2.48 | 2.31 | 2.32 | 31,568 |
| Backtest OncoCyte Corp | | | OncoCyte Corp History | | | OncoCyte Corp Valuation | Previous |
OncoCyte Corp Trading Date Momentum on December 14, 2024
| On December 13 2024 OncoCyte Corp was traded for 2.32 at the closing time. Highest OncoCyte Corp's price during the trading hours was 2.48 and the lowest price during the day was 2.31 . The net volume was 31.6 K. The overall trading history on the 13th of December 2024 did not cause price change. The trading delta at closing time to current price is 6.90% . |
OncoCyte Corp Fundamentals Correlations and Trends
By evaluating OncoCyte Corp's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among OncoCyte Corp's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. OncoCyte financial account trend analysis is a perfect complement when working with valuation or volatility modules.About OncoCyte Corp Stock history
OncoCyte Corp investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for OncoCyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in OncoCyte Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing OncoCyte Corp stock prices may prove useful in developing a viable investing in OncoCyte Corp
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 7.7 M | 8 M | |
| Net Loss | -66.1 M | -62.8 M |
OncoCyte Corp Stock Technical Analysis
OncoCyte Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
OncoCyte Corp Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
OncoCyte Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
OncoCyte Corp December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how OncoCyte Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading OncoCyte Corp shares will generate the highest return on investment. By undertsting and applying OncoCyte Corp stock market strength indicators, traders can identify OncoCyte Corp entry and exit signals to maximize returns
OncoCyte Corp Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for OncoCyte Corp's price direction in advance. Along with the technical and fundamental analysis of OncoCyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of OncoCyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.79) | |||
| Treynor Ratio | 19.8 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for OncoCyte Stock Analysis
When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.